Nonlocal Interactions Stabilize Compact Folding Intermediates in Reduced Unfolded Bovine Pancreatic Trypsin Inhibitor1

David S. Gottfried, Elisha Haas

    Research output: Contribution to journalArticlepeer-review

    61 Scopus citations

    Abstract

    To further our understanding of the protein folding process, it is desirable to examine the structural intermediates (equilibrium and kinetic) that are populated between the statistical coil state and the folded molecule. X-ray crystallography and NMR structural studies are unable to determine longrange distances in proteins under denaturing solution conditions. Nonradiative (Förster) energy transfer, however, has been shown to be a spectroscopic ruler for the measurement of distance distributions and diffusion between selected sites in proteins under a range of different solution conditions. The distributions of distances between a donor probe at the N-terminal residue and an acceptor attached to one of the four lysine residues (15, 26, 41, 46) of reduced and unfolded (in 6 M guanidine hydrochloride and 20 mM dithiothreitol) bovine pancreatic trypsin inhibitor (BPTI) were measured as a function of temperature. Even in strong denaturant and reducing agent, BPTI does not exist as a statistical coil polypeptide. It appears that nonlocal (longrange) interactions are already beginning to “fold” the protein toward a more compact, native conformation. As the temperature is increased under these conditions, hydrophobic interactions lead to an even more compact structure consistent with the predictions of phase diagrams for globular proteins.

    Original languageEnglish
    Pages (from-to)12353-12362
    Number of pages10
    JournalBiochemistry
    Volume31
    Issue number49
    DOIs
    StatePublished - 15 Dec 1992

    Funding

    FundersFunder number
    National Institute of General Medical SciencesR01GM039372

      Fingerprint

      Dive into the research topics of 'Nonlocal Interactions Stabilize Compact Folding Intermediates in Reduced Unfolded Bovine Pancreatic Trypsin Inhibitor1'. Together they form a unique fingerprint.

      Cite this